Literature DB >> 12070141

Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport.

Gunther Marsche1, Astrid Hammer, Olga Oskolkova, Karen F Kozarsky, Wolfgang Sattler, Ernst Malle.   

Abstract

Hypochlorous acid/hypochlorite (HOCl/OCl(-)), a potent oxidant generated in vivo by the myeloperoxidase-H(2)O(2)-chloride system of activated phagocytes, alters the physiological properties of high density lipoprotein (HDL) by generating a proatherogenic lipoprotein particle. On endothelial cells lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) and scavenger receptor class B, type I (SR-BI), act in concert by mediating the holoparticle of and selective cholesteryl ester uptake from HOCl-HDL. We therefore investigated the ligand specificity of HOCl-HDL to SR-BI-overexpressing Chinese hamster ovary cells. Binding of HOCl-HDL was saturable, and the degree of HOCl modification was the determining factor for increased binding affinity to SR-BI. Competition experiments further confirmed that HOCl-HDL binds with increased affinity to the same or overlapping domain(s) of SR-BI as does native HDL. Furthermore, SR-BI-mediated selective HDL-cholesteryl ester association as well as time- and concentration-dependent cholesterol efflux from SR-BI overexpressing Chinese hamster ovary cells were, depending on the degree of HOCl modification of HDL, markedly impaired. The most significant findings of this study were that the presence of very low concentrations of HOCl-HDL severely impaired SR-BI-mediated bidirectional cholesterol flux mediated by native HDL. The colocalization of immunoreactive HOCl-modified epitopes with apolipoprotein A-I along with deposits of lipids in serial sections of human atheroma shown here indicates that the myeloperoxidase-H(2)O(2)-halide system contributes to oxidative damage of HDL in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070141     DOI: 10.1074/jbc.M200503200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  The use of myeloperoxidase as a risk marker for atherosclerosis.

Authors:  Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

2.  The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.

Authors:  Gunther Marsche; Sasa Frank; John G Raynes; Karen F Kozarsky; Wolfgang Sattler; Ernst Malle
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

3.  Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.

Authors:  Gunther Marsche; Sasa Frank; Andelko Hrzenjak; Michael Holzer; Sabine Dirnberger; Christian Wadsack; Hubert Scharnagl; Tatjana Stojakovic; Akos Heinemann; Karl Oettl
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

Review 4.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

5.  Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains.

Authors:  Eleanor C Kennett; Martin D Rees; Ernst Malle; Astrid Hammer; John M Whitelock; Michael J Davies
Journal:  Free Radic Biol Med       Date:  2010-04-21       Impact factor: 7.376

6.  Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro.

Authors:  Gunther Marsche; Paul G Furtmüller; Christian Obinger; Wolfgang Sattler; Ernst Malle
Journal:  Cardiovasc Res       Date:  2008-02-23       Impact factor: 10.787

7.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

8.  Characterization of non-covalent oligomers of proteins treated with hypochlorous acid.

Authors:  Anna L P Chapman; Christine C Winterbourn; Stephen O Brennan; T William Jordan; Anthony J Kettle
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

9.  Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites.

Authors:  Zeenat Ali; Allison A Ellington; Thomas H Mosley; Iftikhar J Kullo
Journal:  Atherosclerosis       Date:  2009-04-05       Impact factor: 5.162

10.  Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease.

Authors:  Zeenat Ali; Paul Sarcia; Thomas H Mosley; Venkateswarlu Kondragunta; Iftikhar J Kullo
Journal:  Vasc Med       Date:  2009-08       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.